Evotec SE (OTCMKTS:EVTCY – Get Free Report) shares hit a new 52-week low during mid-day trading on Monday . The company traded as low as $4.62 and last traded at $4.72, with a volume of 74379 shares changing hands. The stock had previously closed at $4.69.
Evotec Stock Performance
The company has a current ratio of 2.57, a quick ratio of 2.50 and a debt-to-equity ratio of 0.53. The firm has a market capitalization of $1.51 billion, a price-to-earnings ratio of 11.17 and a beta of 0.98. The company has a 50-day moving average of $4.39 and a 200-day moving average of $4.30.
Evotec Company Profile
Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties.
Further Reading
- Five stocks we like better than Evotec
- How to Use Stock Screeners to Find Stocks
- Tesla Poised to Hit Record Highs This Holiday Season
- Canadian Penny Stocks: Can They Make You Rich?
- The Salesforce Rally is Just Getting Started: Here’s Why
- Comparing and Trading High PE Ratio Stocks
- 3 Chip and Data Center Stocks That Can Keep Rising in 2025
Receive News & Ratings for Evotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec and related companies with MarketBeat.com's FREE daily email newsletter.